Leonard J Rubinstein

Title: Leonard J Rubinstein: Innovator in Virus Neutralization Assays

Introduction

Leonard J Rubinstein is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of virology through his innovative patent. His work focuses on improving the efficiency of virus neutralization assays, which are crucial for understanding viral infections and developing treatments.

Latest Patents

Rubinstein holds a patent for a "Virus neutralization assay utilizing imaging cytometry." This invention describes a virus reduction neutralization test (VRNT) that serves as a rapid, high throughput alternative to traditional low throughput and labor-intensive neutralization assays. The VRNT employs imaging cytometry to count virus-infected cells approximately one day post-infection. This advancement eliminates the lengthy wait times associated with other assays, significantly reducing overall assay time and increasing throughput by at least 15-fold.

Career Highlights

Throughout his career, Rubinstein has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme LLC and Merck Sharp + Dohme Corp. His experience in these organizations has allowed him to develop and refine his innovative approaches to virology.

Collaborations

Rubinstein has collaborated with esteemed colleagues such as Joseph M Antonello and Leah A Bogardus. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Leonard J Rubinstein's contributions to the field of virology through his innovative patent demonstrate his commitment to enhancing the efficiency of virus neutralization assays. His work not only advances scientific understanding but also has the potential to impact public health positively.